Back
Wayfair Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
56
W
Wayfair
Last Price:
69.00
Seasonality Move:
37.97%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
42.42
Seasonality Move:
12.29%
Buy
56
Wayfair (W)
is a Buy
Is Wayfair a Buy, Sell or Hold?
- The current Wayfair [W] share price is $71.06. The Score for W is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- W is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
W Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
W Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 65.05 | Buy |
| Chaikin Money Flow: | -3211275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.32 - 68) | Buy |
| Bollinger Bands (100): | (52.3 - 64.78) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.38 | Sell |
| Relative Strength Index (14 RSI): | 36.17 | Sell |
| Chaikin Money Flow: | -526969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.16 - 45.34) | Sell |
| Bollinger Bands (100): | (43.31 - 49.39) | Sell |
W Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.45 | Buy |
| 20-day SMA: | 60.72 | Buy |
| 50-day SMA: | 61.66 | Buy |
| 200-day SMA: | 58.8 | Buy |
| 8-day EMA: | 68.87 | Buy |
| 20-day EMA: | 64.32 | Buy |
| 50-day EMA: | 61.26 | Buy |
| 200-day EMA: | 58.03 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.46 | Sell |
| 20-day SMA: | 42.72 | Sell |
| 50-day SMA: | 45.61 | Sell |
| 200-day SMA: | 42.06 | Sell |
| 8-day EMA: | 41.51 | Sell |
| 20-day EMA: | 42.79 | Sell |
| 50-day EMA: | 44.59 | Sell |
| 200-day EMA: | 44.26 | Sell |
Wayfair Earnings Growth & W Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.87 per share, an increase next quarter of $0.31 per share, an increase this year of $2.29 per share, and an increase next year of $0.96 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Wayfair Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||